{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:45:58Z","timestamp":1778499958995,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03227-4","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:41:41Z","timestamp":1737650501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The efficacy and safety of Bevacizumab-based treatments in Optic Pathway Glioma among pediatric population: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-1158","authenticated-orcid":false,"given":"Bardia","family":"Hajikarimloo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-6869","authenticated-orcid":false,"given":"Salem M.","family":"Tos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Kooshki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadamin Sabbagh","family":"Alvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Hasanzade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hossein","family":"Zare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hessam","family":"Zare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roozbeh","family":"Tavanaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadhosein","family":"Akhlaghpasand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorsa","family":"Najari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-6925","authenticated-orcid":false,"given":"Mohammad Amin","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"3227_CR1","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.3390\/jcm12216709","volume":"12","author":"M Modrzejewska","year":"2023","unstructured":"Modrzejewska M, Olejnik-Wojciechowska J, Roszyk A et al (2023) Optic pathway gliomas in pediatric population\u2014current approach in diagnosis and management: literature review. JCM 12:6709. https:\/\/doi.org\/10.3390\/jcm12216709","journal-title":"JCM"},{"key":"3227_CR2","doi-asserted-by":"publisher","first-page":"789856","DOI":"10.3389\/fonc.2022.789856","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Chen Y, Qin X et al (2022) Epidemiology and survival of patients with optic pathway gliomas: a population-based analysis. Front Oncol 12:789856. https:\/\/doi.org\/10.3389\/fonc.2022.789856","journal-title":"Front Oncol"},{"key":"3227_CR3","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.3390\/cancers14246087","volume":"14","author":"CAM Bennebroek","year":"2022","unstructured":"Bennebroek CAM, Van Zwol J, Porro GL et al (2022) Impact of Bevacizumab on visual function, tumor size, and toxicity in pediatric progressive optic pathway glioma: a retrospective nationwide multicentre study. Cancers 14:6087. https:\/\/doi.org\/10.3390\/cancers14246087","journal-title":"Cancers"},{"key":"3227_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-023-04516-y","volume":"166","author":"CA Bennebroek","year":"2024","unstructured":"Bennebroek CA, Schouten CR, Montauban-van Swijndregt MC et al (2024) Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components. J Neurooncol 166:79\u201387. https:\/\/doi.org\/10.1007\/s11060-023-04516-y","journal-title":"J Neurooncol"},{"key":"3227_CR5","doi-asserted-by":"publisher","first-page":"e30668","DOI":"10.1002\/pbc.30668","volume":"70","author":"BI Siegel","year":"2023","unstructured":"Siegel BI, Nelson D, Peragallo JH et al (2023) Visual outcomes after bevacizumab-based therapy for optic pathway glioma. Pediatr Blood Cancer 70:e30668. https:\/\/doi.org\/10.1002\/pbc.30668","journal-title":"Pediatr Blood Cancer"},{"key":"3227_CR6","doi-asserted-by":"publisher","first-page":"100115","DOI":"10.1016\/j.ejcped.2023.100115","volume":"2","author":"M Sim\u00e3o-Rafael","year":"2023","unstructured":"Sim\u00e3o-Rafael M, Cruz O, Perez-Jaume S et al (2023) Use of bevacizumab in pediatric low-grade glioma: ten-year experience in a single center. EJC Pediatr Oncol 2:100115. https:\/\/doi.org\/10.1016\/j.ejcped.2023.100115","journal-title":"EJC Pediatr Oncol"},{"key":"3227_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11060-022-03970-4","volume":"157","author":"C De Marcellus","year":"2022","unstructured":"De Marcellus C, Tauzi\u00e8de-Espariat A, Cuinet A et al (2022) The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients. J Neurooncol 157:355\u2013364. https:\/\/doi.org\/10.1007\/s11060-022-03970-4","journal-title":"J Neurooncol"},{"key":"3227_CR8","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/cancers15041036","volume":"15","author":"P Cal\u00f2","year":"2023","unstructured":"Cal\u00f2 P, Pianton N, Basle A et al (2023) Bevacizumab as single Agent in Children and teenagers with Optic Pathway Glioma. Cancers 15:1036. https:\/\/doi.org\/10.3390\/cancers15041036","journal-title":"Cancers"},{"key":"3227_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MPH.0000000000002753","volume":"45","author":"P Panagopoulou","year":"2023","unstructured":"Panagopoulou P, Athanasiadis D, \u0391nastasiou \u0391 et al (2023) Pediatric optic pathway gliomas: a report from Northern Greece. J Pediatr Hematol Oncol 45:445\u2013451. https:\/\/doi.org\/10.1097\/MPH.0000000000002753","journal-title":"J Pediatr Hematol Oncol"},{"key":"3227_CR10","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ: n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"3227_CR11","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016)  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ: i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","DOI":"10.1136\/bmj.i4919"},{"key":"3227_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT (2021) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods 12:55\u201361. https:\/\/doi.org\/10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"3227_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ICU.0000000000000587","volume":"30","author":"MK Farazdaghi","year":"2019","unstructured":"Farazdaghi MK, Katowitz WR, Avery RA (2019) Current treatment of optic nerve gliomas. Curr Opin Ophthalmol 30:356\u2013363. https:\/\/doi.org\/10.1097\/ICU.0000000000000587","journal-title":"Curr Opin Ophthalmol"},{"key":"3227_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/nop\/npz076","volume":"7","author":"VM Lu","year":"2020","unstructured":"Lu VM, Welby JP, Nesvick CL, Daniels DJ (2020) Efficacy and safety of bevacizumab in progressive pediatric low-grade glioma: a systematic review and meta-analysis of outcome rates. Neuro-Oncology Pract 7:359\u2013368. https:\/\/doi.org\/10.1093\/nop\/npz076","journal-title":"Neuro-Oncology Pract"},{"key":"3227_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/neuonc\/noq033","volume":"12","author":"A Narayana","year":"2010","unstructured":"Narayana A, Kunnakkat S, Chacko-Mathew J et al (2010) Bevacizumab in recurrent high-grade pediatric gliomas. Neurooncology 12:985\u2013990. https:\/\/doi.org\/10.1093\/neuonc\/noq033","journal-title":"Neurooncology"},{"key":"3227_CR16","doi-asserted-by":"publisher","first-page":"vdad174","DOI":"10.1093\/noajnl\/vdad174","volume":"6","author":"G Sferruzza","year":"2024","unstructured":"Sferruzza G, Malcangi M, Bosco L, Finocchiaro G (2024) Reassessing the efficacy of bevacizumab in newly diagnosed glioblastoma: a systematic review and external pseudodata-based analysis. Neuro-Oncology Adv 6:vdad174. https:\/\/doi.org\/10.1093\/noajnl\/vdad174","journal-title":"Neuro-Oncology Adv"},{"key":"3227_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/neuonc\/noac223","volume":"25","author":"K Green","year":"2023","unstructured":"Green K, Panagopoulou P, D\u2019Arco F et al (2023) A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes. Neurooncology 25:774\u2013785. https:\/\/doi.org\/10.1093\/neuonc\/noac223","journal-title":"Neurooncology"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03227-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:13:25Z","timestamp":1772079205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03227-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3227"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03227-4","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is deemed exempt from receiving ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}